Roy Beveridge

Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting

Marcus A. Neubauer, J. Russell Hoverman, Michael Kolodziej et al. · Journal of Oncology Practice · 2010 · 173 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +13

High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study

Raymond B. Weiss, Robert M. Rifkin, F. Marc Stewart et al. · The Lancet · 2000 · 163 citations

Medicine, Oncology, Breast Oncology +6

High-Dose Chemotherapy With Reinfusion of Purged Autologous Bone Marrow Following Dose-Intense Induction as Initial Therapy for Metastatic Breast Cancer

M. J. Kennedy, Roy Beveridge, S. D. Rowley et al. · JNCI Journal of the National Cancer Institute · 1991 · 155 citations

Medicine, Oncology, Pharmacotherapy +17

Integrating Palliative Care Into the Outpatient, Private Practice Oncology Setting

J. Cameron Muir, Farrah N. Daly, Malene S. Davis et al. · Journal of Pain and Symptom Management · 2010 · 122 citations · Full text

Medicine, Oncology, End-of-life Care +13

Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease.

D. W. Chan, Roy Beveridge, H Muss et al. · Journal of Clinical Oncology · 1997 · 117 citations

Medicine, Immunology, Oncology +10